Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical Trial

The current curative approaches for ischemia/reperfusion injury on liver transplantation are still under debate for their safety and efficacy in patients with end-stage liver disease. We present the SIMVA statin donor treatment before Liver Transplants study. METHODS. SIMVA statin donor treatment be...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagano, Duilio, Bosch, Jaime, Tuzzolino, Fabio, Oliva, Elisabetta, Ekser, Burcin, Zito, Giovanni, Cintorino, Davide, di Francesco, Fabrizio, Li Petri, Sergio, Ricotta, Calogero, Bonsignore, Pasquale, Calamia, Sergio, Magro, Bianca, Trifirò, Gianluca, Alduino, Rossella, Barbara, Marco, Conaldi, Pier Giulio, Gallo, Alessia, Venuti, Francesca, Luca, Angelo, Gruttadauria, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Clinical Science—Liver
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698118/
https://www.ncbi.nlm.nih.gov/pubmed/35862782
http://dx.doi.org/10.1097/TP.0000000000004220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698118/
https://www.ncbi.nlm.nih.gov/pubmed/35862782
http://dx.doi.org/10.1097/TP.0000000000004220

Ejemplares similares